Next Article in Journal
Health Effects of Grape Seed and Skin Extracts and Their Influence on Biochemical Markers
Previous Article in Journal
Pharmacological Characterization of 4-Methylthioamphetamine Derivatives
Previous Article in Special Issue
Characterization of Ciprofloxacin-Bismuth-Loaded Antibacterial Wound Dressing
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

DNA Intercalating Near-Infrared Luminescent Lanthanide Complexes Containing Dipyrido[3,2-a:2′,3′-c]phenazine (dppz) Ligands: Synthesis, Crystal Structures, Stability, Luminescence Properties and CT-DNA Interaction

by
Aleksandar Savić
1,2,
Anna M. Kaczmarek
1,3,
Rik Van Deun
1,* and
Kristof Van Hecke
4,*
1
L3–Luminescent Lanthanide Lab, Department of Chemistry, Ghent University, Krijgslaan 281-S3, B-9000 Ghent, Belgium
2
Chair of General and Inorganic Chemistry, Faculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia
3
NanoSensing Group, Department of Chemistry, Ghent University, Krijgslaan 281-S3, B-9000 Ghent, Belgium
4
XStruct, Department of Chemistry, Ghent University, Krijgslaan 281-S3, B-9000 Ghent, Belgium
*
Authors to whom correspondence should be addressed.
Molecules 2020, 25(22), 5309; https://doi.org/10.3390/molecules25225309
Submission received: 30 September 2020 / Revised: 9 November 2020 / Accepted: 9 November 2020 / Published: 13 November 2020
(This article belongs to the Special Issue Metal Coordination Complexes for Biomedical Applications)

Abstract

:
In order to create near-infrared (NIR) luminescent lanthanide complexes suitable for DNA-interaction, novel lanthanide dppz complexes with general formula [Ln(NO3)3(dppz)2] (Ln = Nd3+, Er3+ and Yb3+; dppz = dipyrido[3,2-a:2′,3′-c]phenazine) were synthesized, characterized and their luminescence properties were investigated. In addition, analogous compounds with other lanthanide ions (Ln = Ce3+, Pr3+, Sm3+, Eu3+, Tb3+, Dy3+, Ho3+, Tm3+, Lu3+) were prepared. All complexes were characterized by IR spectroscopy and elemental analysis. Single-crystal X-ray diffraction analysis of the complexes (Ln = La3+, Ce3+, Pr3+, Nd3+, Eu3+, Er3+, Yb3+, Lu3+) showed that the lanthanide’s first coordination sphere can be described as a bicapped dodecahedron, made up of two bidentate dppz ligands and three bidentate-coordinating nitrate anions. Efficient energy transfer was observed from the dppz ligand to the lanthanide ion (Nd3+, Er3+ and Yb3+), while relatively high luminescence lifetimes were detected for these complexes. In their excitation spectra, the maximum of the strong broad band is located at around 385 nm and this wavelength was further used for excitation of the chosen complexes. In their emission spectra, the following characteristic NIR emission peaks were observed: for a) Nd3+: 4F3/24I9/2 (870.8 nm), 4F3/24I11/2 (1052.7 nm) and 4F3/24I13/2 (1334.5 nm); b) Er3+: 4I13/24I15/2 (1529.0 nm) c) Yb3+: 2F5/22F7/2 (977.6 nm). While its low triplet energy level is ideally suited for efficient sensitization of Nd3+ and Er3+, the dppz ligand is considered not favorable as a sensitizer for most of the visible emitting lanthanide ions, due to its low-lying triplet level, which is too low for the accepting levels of most visible emitting lanthanides. Furthermore, the DNA intercalation ability of the [Nd(NO3)3(dppz)2] complex with calf thymus DNA (CT-DNA) was confirmed using fluorescence spectroscopy.

1. Introduction

Lanthanide chemistry is a field of inorganic chemistry that is constantly evolving, particularly in recent decades, as a growing number of synthesized compounds are widely used in different areas. One of the most fascinating aspects of trivalent lanthanides is their unique luminescence properties [1,2,3]. They show characteristic narrow line-like emission peaks, ranging from the UV-visible (UV/Vis) to near-infrared (NIR), and in suitable hosts even in the mid-infrared (MIR) region, exhibiting relatively long luminescence lifetimes. Yet, a downside of trivalent lanthanides is that their f-f transitions are parity forbidden, and therefore their absorption coefficients are very low. This results in low emission intensities unless the compound is excited with high power sources, e.g., lasers. The design of lanthanide complexes with organic ligands, which are strongly absorbing chromophores, is an ideal way to overcome this drawback.
The unique properties (structural, optical and magnetic) of the lanthanide complexes allow them to be used in a wide range of applications [4]. In the field of biology and medicine these complexes are particularly investigated [5]. They are already being employed or show great potential as MRI contrast agents (Gd3+ compounds), fluorescent probes and bioresponsive cellular imaging agents, as well as artificial nucleases for cleavage of RNA or DNA [6,7,8]. Recently, studies have shown that other lanthanide compounds, such as oxide nanoparticles (e.g., CeO2), nanodrums and nanocrystals, as well as radioisotopes (e.g., 177Lu), represent very promising agents in cancer imaging and therapy [9,10]. Lanthanides usually have the +3 oxidation state and the significant redox stability of this oxidation state is very important for cellular applications, especially for hypoxic cancer cells [5]. The ability of rapid ligand exchange rates and strong Lewis acidity of the trivalent lanthanide ions and their complexes make them suitable in application as artificial nucleases for cleavage of RNA or DNA.
This study originated from our interest to design lanthanide complexes, which are highly emissive in the NIR region (780–2500 nm wavelength). In the aspect of biological applications, luminescent materials emitting in the NIR region of the electromagnetic spectrum have several advantages over visible emitting materials. Among the most important is that they are safer for biological tissues and result in better optical imaging resolution [11]. Biological tissue is also more transparent for NIR light than for visible or UV light, hence allowing imaging of deeper-lying tumor cells. Several of the trivalent lanthanide ions show NIR emission, given the right circumstances, such as Er3+, Ho3+, Tm3+, Pr3+, Yb3+, Nd3+, Sm3+ and Dy3+ [12]. Among them, Nd3+, Er3+ and Yb3+ are most often investigated.
Many efforts have already been invested in the design of relatively stable complexes of f-elements, which can be photoactivated upon light irradiation [13,14,15,16]. However, the design of highly emissive lanthanide complexes in the NIR region can be quite challenging and the choice of an appropriate organic ligand is crucial. We have focused our work on the design of lanthanide complexes with dipyrido[3,2-a:2′,3′-c]phenazine (dppz) as its triplet level is ideally suited for efficient sensitization of Nd3+, Er3+ and Yb3+ ions [17]. For example, a highly luminescent [Er(bta)3(dppz)] (Hbta = benzoyltrifluoroacetone) complex has previously been reported [18]. It exhibited stronger NIR emission than similar complexes prepared with the Hbta ligand and bipyridine, phenanthroline or dipyrido[3,2-d:2′,3′-f]quinoxaline. Recently, an [Yb(L)3(dppz)] (L = 3,5-heptanedione) complex has been reported, showing strong NIR luminescence and the incorporation of such complexes in poly(methyl methacrylate) (PMMA) thin films was studied for potential biological applications [19]. Ytterbium(III) complexes, such as [Yb(dppz)(DMF)2Cl3] and [Yb(dppz)(ttfa)3] (Httfa = 4,4,4-trifluoro-1-(2-thienyl)-1,3-butanedione) have been designed as NIR bioimaging probes using cooperative upconversion luminescence for theranostic application in the biological phototherapeutic window [20]. Another feature of polypyridyl ligands such as dppz is their ability to interact with DNA tracts [21], rendering them perfect candidates as NIR luminescent probes for cellular imaging and diagnostics, when combined with specific lanthanides. Here, in our pursuit to obtain compounds with strong NIR luminescence properties we have designed complexes, which consist of one lanthanide ion (Ln = Nd3+, Er3+ and Yb3+) and two dppz ligands. In all these complexes the lanthanide ions are ten-coordinated by two bidentate N,N-donor dppz ligands and three bidentate nitrate ions. We also synthesized analogous complexes with other lanthanide ions (Ln = Ce3+, Pr3+, Nd3+, Sm3+, Eu3+, Tb3+, Dy3+, Ho3+, Tm3+, Lu3+) and single crystals suitable for X-ray diffraction analysis were obtained for several of the Ln3+ complexes (Ln = La3+, Ce3+, Pr3+, Nd3+, Eu3+, Er3+,Yb3+, Lu3+). This shows that our synthetic approach, which is novel compared to other syntheses reported for phenazine complexes, is highly successful in yielding single crystals suitable for measurements of analogous structures. A detailed luminescence study of the [Nd(NO3)3(dppz)2], [Er(NO3)3(dppz)2] and [Yb(NO3)3(dppz)2] complexes was carried out and is presented in this paper. Additionally, the stability of the compounds in solution is verified by UV-Vis spectroscopy. Last, the intercalation ability of the [Nd(NO3)3(dppz)2] with calf thymus DNA (CT-DNA) was tested using fluorescence spectroscopy.

2. Results and Discussion

2.1. Synthesis of the Ligand and Complexes

The synthesis of the ligand precursor 1,10-phenanthroline-5,6-dione and of the dipyrido[3,2-a:2′,3′-c]phenazine ligand are presented in the supporting information (Schemes S1 and S2).
Complexes of general formula [Ln(NO3)3(dppz)2] (Ln = Ce3+, Pr3+, Nd3+, Sm3+, Eu3+, Tb3+, Dy3+, Ho3+, Er3+, Tm3+, Yb3+, Lu3+) were prepared by the reaction of the lanthanide nitrite salt and the dppz ligand in 1:2 molar ratio (Scheme 1). Reactions were performed in a mixture methanol/nitromethane at 40 °C, for 2 h. The complexes precipitated directly from the reaction mixture in moderate yields. The complexes are all soluble in dimethyl sulfoxide (DMSO) and dimethylformamide (DMF). The complexes [Ln(NO3)3(dppz)2] (Ln = La3+ and Gd3+) have previously been reported and hence are not included in the series [22].

2.2. Spectroscopic Study

1,10-Phenantroline-5,6-dione and the dipyrido[3,2-a:2′,3′-c]phenazine (dppz) ligand were characterized by IR and 1H-NMR spectroscopy. These compounds have already been described in literature and the positions of the bands in the IR spectra and chemical shift values in the 1H-NMR spectra are in accordance with the literature data [23,24] (see Materials and Methods, parts: 3.1., 3.3.1. and 3.3.2.). The IR spectrum of 1,10-phenantroline-5,6-dione showed characteristic bands at the following wavenumber positions: around 3062 cm−1 (C-H stretching vibrations), 1686 (C=O stretching vibrations), 1580–1562 and 1460–1418 cm−1 (C-C and C-N stretching vibrations in the ring). Characteristic bands of the dppz molecule were detected also at expected positions: around 3026 cm−1 (C-H stretching vibrations), 1589–1575 and 1485–1361 cm−1 (C-C and C-N stretching vibrations in the ring).
The IR spectra of all the complexes showed characteristic bands at the following wavenumber positions: around 3095 cm−1 (C-H stretching vibrations), 1600–1585 and 1500–1400 cm−1 (C-C and C-N stretching vibrations in the ring), 900–675 cm−1 (out-of-plane bends).

2.3. Single Crystal X-ray Analysis

A whole series of eight [Ln(NO3)3(dppz)2] complexes (Ln = La3+, Ce3+, Pr3+, Nd3+, Eu3+, Er3+, Yb3+ and Lu3+) were structurally characterized by single-crystal X-ray analysis. Although the [La(NO3)3(dppz)2] complex has previously been reported [22], its crystal structure has never been reported and is therefore included in the reported series. All structures were found to be isomorphic and exist as neutral, mononuclear species. Therefore, only the [Nd(NO3)3(dppz)2] complex is described as an example.
The complex [Nd(NO3)3(dppz)2] crystallized in the centro-symmetric space group P21/c, with one complete [Nd(NO3)3(dppz)2] complex as the asymmetric unit. The Nd3+ center is ten-coordinated by two bidentately coordinating N,N’-donor dppz ligands and three O,O’-bidentate nitrate ligands (Figure 1).
The coordination environment around Nd3+ can be best described as a bicapped dodecahedron geometry. As a consequence, the two dppz ligands are oppositely oriented, with an angle of 78.5° between the ligands. The Nd-O distances are in the range of 2.516(3) to 2.600(3) Å. The Nd-N distances are in the range of 2.590(3) to 2.629(3) Å.
In the packing, multiple π∙∙∙π stacking interactions are observed between the dppz aromatic rings (centroid-centroid distances of 3.653(2)–3.842(2)Å for distances <4Å). Furthermore, the nitrate ligands form N-O∙∙∙π interactions with several dppz aromatic rings (N-O∙∙∙centroid distances between 3.059(3)–3.931(3)Å).
An isostructural compound of the Eu3+ complex has previously been reported, however, this latter compound crystallized in the different space group C2/c, and featured inclusions of an extra dppz ligand and diethylether molecule in the crystal packing [25].

2.4. Photoluminescence Study

The [Ln(NO3)3(dppz)2] complexes containing spectroscopically active lanthanide ions were tested for their luminescence properties. All measurements were carried out in the solid state. It was observed that only the [Nd(NO3)3(dppz)2], [Er(NO3)3(dppz)2], [Yb(NO3)3(dppz)2] and [Eu(NO3)3(dppz)2] complexes displayed luminescence properties when excited into the maximum of the broad band originating from the dppz ligand. The NIR luminescence properties of the Nd3+, Er3+ and Yb3+ complexes are discussed in detail in this paper. For the sake of completeness, the excitation and emission spectra of the [Eu(NO3)3(dppz)2] complex are presented in the SI (Figures S1 and S2). The singlet and triplet energy levels of the dppz ligand have been previously reported in the literature (37000 and 18600 cm−1) [22]. It is known that the intersystem crossing process becomes effective when ΔE (1ππ*−3ππ*), the energy difference between the first excited singlet and triplet levels of the ligand, is more than 5000 cm−1 [26]. For the dppz ligand, the energy gap between the 1ππ* and 3ππ* amounts to 18400 cm−1, which indicates an effective intersystem crossing process. A study of the ligand’s triplet energy level and the resonant energy levels of the various lanthanides allows to predict whether efficient ligand-to-metal energy transfer can occur between the chosen ligand and a particular lanthanide ion. The ligand triplet energy level must be obviously higher than the resonant energy level of the lanthanide to result in adequate ligand to metal energy transfer. Of course, most likely the energy is not transferred directly to the emitting level of the lanthanide, but to higher levels, which then relax to the emitting levels via a nonradiative way. In Scheme 2 we present the singlet and triplet energy levels of dppz and of some selected spectroscopically active lanthanide ions. This clearly shows that the dppz ligand is very well suited for the design of NIR emitting Nd3+, Er3+ and Yb3+ complexes. On the other hand, the low triplet energy level of dppz makes it rather unfavorable as a sensitizer for most of the visible emitting lanthanide ions (e.g., Sm3+, Tb3+, Dy3+). Nevertheless, we were able to observe visible red emission for the [Eu(NO3)3(dppz)2] complex (studied in solid state, DMF and a DMF-H2O mixture; Figures S1 and S2).
Steady-state excitation and emission spectra of the Nd3+, Er3+ and Yb3+ complexes were recorded at room temperature. For all three complexes, the excitation spectrum consisted of a strong broad band in the region 250–500 nm with a maximum at around 385.0 nm (Figure 2, Figure 3 and Figure 4). For [Nd(NO3)3(dppz)2], additionally several narrow sharp peaks were present, which could be assigned to the f-f transitions of Nd3+ (Table 1). When exciting the [Nd(NO3)3(dppz)2] complex at 385.0 nm the three characteristic NIR emission peaks of Nd3+ were recorded: 4F3/24I9/2 (870.8 nm), 4F3/24I11/2 (1052.7 nm), and 4F3/24I13/2 (1334.5 nm). The luminescence lifetime of the complex was also recorded. The decay curve of this compound as well as the [Er(NO3)3(dppz)2] and [Yb(NO3)3(dppz)2] complex could be well fitted using the single exponential equation:
I = I 0 exp t τ
where I and I0 are the luminescence intensities at time t and 0, respectively, and τ is the luminescence lifetime. The decay time of the [Nd(NO3)3(dppz)2] complex was determined to be 1624 ns or 1.62 µs (Figure 5).
When exciting the [Er(NO3)3(dppz)2] complex at 385.0 nm one strong, broad peak located at 1529.0 nm, which can be assigned to the 4I13/24I15/2 “telecom” transition, was observed. The luminescence lifetime was recorded for this complex and was determined as 2295 ns or 2.30 µs (Figure 6).
Exciting the [Yb(NO3)3(dppz)2] complex at 385.0 nm resulted in a strong broad peak with a maximum at 977.6 nm. This peak could be assigned to the 2F5/22F7/2 transition of Yb3+. The decay time of the complex was calculated to be 9765 nm or 9.77 µs (Figure 7).
The fact that the decay curves of the three complexes could be well fitted by monoexponential functions indicates the presence of single luminescence sites in the compounds, which is confirmed by the crystal structures.
The [Nd(NO3)3(dppz)2], [Er(NO3)3(dppz)2], [Yb(NO3)3(dppz)2] complexes show good luminescence properties, confirming that the dppz ligand is very well suited for the design of NIR emitting Nd3+, Er3+ and Yb3+ complexes. The dppz triplet level is well matched with the resonant energy levels of the two lanthanides Nd3+ and Er3+, allowing efficient energy transfer from the ligand to the lanthanide ions. Additionally, there are no water molecules in the first coordination sphere of the lanthanide minimizing non-radiative deactivation. To the best of our knowledge, so far only the luminescence properties of an [Er(bta)3(dppz)] complex have been reported for NIR-emitting lanthanide dppz complexes [18]. This compound has a higher decay time compared to our [Er(NO3)3(dppz)2] complex. This is quite expected due to the presence of a fluorinated Hbta ligand, as it is known that Er3+ complexes with fluorinated ligands have exceptionally long decay times (e.g., 16.8 µs for a complex with 1,1,1,3,5,5,5-heptafluoropentane-2,4-dione) [27,28].

2.5. UV/Vis Stability Tests

In order to enable the [Ln(NO3)3(dppz)2] complexes to have real application in biological environment it is necessary that they remain stable in solution over a certain period of time. Therefore, the stability of the [Nd(NO3)3(dppz)2], [Er(NO3)3(dppz)2] and [Yb(NO3)3(dppz)2] samples was tested over a period of 6 h. As can be found in literature the electronic absorption spectra of the dppz complexes in DMF show a ligand centered π→π* transition at around 265 nm. Two bands at 361 nm and 380 nm assigned to the n→π* transitions of the phenazine moiety are also present in the UV/Vis spectra [22,29]. In order to rule out decomposition of the complexes over time absorption spectral traces of the [Nd(NO3)3(dppz)2] in DMF were measured over a period of up to 6 h (Figure 8). No significant changes are visible in the spectra. Similar experiments were carried out for the [Er(NO3)3(dppz)2] and [Yb(NO3)3(dppz)2] compounds and exhibited no appreciable changes in the UV/Vis spectra over time (Figures S3 and S4). Our UV-Vis spectra are recorded in the 280–500 nm region to observe the n→π* transitions of the phenazine moiety. The complexes were also soluble in a mixture of DMF/Tris buffer (5 mM Tris-HCl, 5 mM NaCl, pH 7.2) and weakly soluble in only the Tris buffer (Figures S4 and S5).
To further investigate the stability of these [Ln(NO3)3(dppz)2] complexes, we have analyzed the [Eu(NO3)3(dppz)2] complex in different environments. It is known, that in europium compounds the splitting of the 5D07F0–6 peaks contains information on the europium ion’s environment [2]. Therefore, europium is often referred to as a structural probe. We have performed measurements of the [Eu(NO3)3(dppz)2] complex in solid, DMF and 50%DMF + 50%H2O mixture (see Figures S1 and S2). All emission spectra have been recorded upon exciting into the maximum of the dppz ligand’s absorption band at 370 nm. As can be observed, there are some changes in the emission spectra measured in the different environments, but it is clear that the red emission of the Eu3+ is retained even in 50%DMF + 50%H2O. However, the excitation spectra recorded in the three cases look remarkably similar (apart from the 5L67F0 peak slightly below 400 nm in the solid state spectrum). This clearly indicates that the Eu3+ ion remains coordinated by at least one of the dppz ligands even after dissolution in DMF and after adding additional distilled water. In order to investigate whether indeed a different complex would be present after dissolution in DMF or DMF/water mixture, the luminescence decay traces were recorded in H2O and D2O to determine the number of directly coordinated water molecules using the Horrock’s equation [30,31] (Figures S7–S10). In fact, DMF/H2O 50/50 and DMF/D2O 50/50 mixtures were used as the complex isn’t sufficiently soluble in pure H2O or D2O. This yielded a number of coordinated water molecules of 3.73, pointing to the coordination of three or four water molecules to the Eu3+ ion. Given the fact that at least one dppz ligand should remain coordinated to the Eu3+ ion, simply replacing one dppz ligand with water molecules would not yield a number of three to four directly coordinated water molecules. As the excitation spectra are almost identical in the three cases, it is more likely that some of the nitrate ions that coordinate to the Eu3+ ion are replaced by water or DMF molecules (the nitrates remaining in the second coordination sphere for example) upon dissolution, resulting in a local coordination site at the Eu3+ ion that is less dissimilar to the original one in the solid state. It can therefore be assumed that indeed changes in the complex’s composition may occur upon dissolution in DMF or a DMF/water mixture, but most likely this does not involve drastic rearrangements such as the loss of the dppz ligands. As all reported complexes are isostructural, we expect similar behavior of the whole series of compounds.

2.6. CT-DNA Interaction Tests

In order to assess if the obtained [Ln(NO3)3(dppz)2] complexes show DNA interaction ability we carried out an ethidium bromide (EthB) displacement assay with CT-DNA in the presence of the [Nd(NO3)3(dppz)2] complex as an example. EthB is employed as a spectral probe, which shows enhanced emission intensity when intercalated to DNA and reduced emission intensity in the free state in water or buffer medium (due to solvent quenching of the fluorescence). The competitive interaction of the [Nd(NO3)3(dppz)2] complex, which could result in the displacement of the CT-DNA intercalated EthB, was monitored using fluorescence spectroscopy.
Figure 9 presents the emission spectra of EthB, EthB pretreated with CT-DNA, and EthB pretreated with CT-DNA and increasing additions of the [Nd(NO3)3(dppz)2] complex. As noticed, based on the figure, with increasing [Nd(NO3)3(dppz)2] concentration, the EthB emission intensity decreases. This means that the [Nd(NO3)3(dppz)2] complex shows sufficient interaction ability to the CT-DNA. With increasing [Nd(NO3)3(dppz)2] concentration an increased amount if EthB is displaced from the CT-DNA and is hence in the free state in the buffer. Due to solvent quenching, a drop in the emission intensity is clearly observed.
The apparent binding constant Kapp of the [Nd(NO3)3(dppz)2] complex to the CT-DNA was determined using the equation KEthB [EthB] = Kapp C50, where KEthB is the binding constant of EthB (1.0 107 M−1, [EthB] is the EthB concentration (1.27 mM) and C50 is the concentration of the [Nd(NO3)3(dppz)2] complex at 50% reduction of the fluorescence intensity of the EthB (323.6 μM; based on the Stern–Volmer plot of I/I0 vs [complex]; see Supplementary Materials) [20,32]. The Kapp equals 3.9 107 M−1, indicating high affinity to CT-DNA, most probably through a DNA intercalative mode. A similar value of 1.2 107 M−1 was found for a [Pt(pydppz)Cl]Cl (pydppz = 6-(2-pyridyl)-dipyrido-[3,2-a:2′,3′-c]phenazine) complex [33], while lower values of ∼1.3–6.0 106 M−1 have often been reported for other lanthanide dppz complexes [20,25,29].

3. Materials and Methods

3.1. Synthesis

All chemicals (analytical grade) were purchased from Sigma Aldrich, VWR, Acros Organics or Merck Chemicals and used without further purification. The calf thymus DNA (CT-DNA) was Type 1, fibers, and was purchased from Sigma Aldrich. The precursor ligand, 1,10-phenantroline-5,6-dione and the dipyrido[3,2-a:2′,3′-c]phenazine ligand were synthesized according to literature procedures with slight modifications [23,24].

3.2. Characterization

Elemental analysis (C, H, N) was carried out with a Thermo Scientific Flash 2000 Series CHNS/O analyzer.
IR spectra were recorded from 4000 to 650 cm−1, on a Thermo Scientific FT-IR spectrometer (type Nicolet 6700), equipped with a DRIFTS-cell, using KBr as a non-absorbing matrix.
Photoluminescence measurements were recorded on an Edinburgh Instruments FLSP920 UV/Vis-NIR spectrofluorometer, using a 450 W xenon lamp as the steady state excitation source and a Hamamatsu R5509-72 photomultiplier operating at −80 °C. For the Eu3+ spectrum, a Hamamatsu R928P PMT was used, for the 200–900 nm range. The time-resolved measurements were performed using a Continuum Surelite I laser (450 mJ @1064 nm), operating at a repetition rate of 10 Hz and using the third harmonic (355 nm) as the excitation source, and the photomultiplier detector mentioned above. For all compounds, the luminescence of solid samples was recorded. Small amounts of the powder were placed between quartz plates.
UV/Vis measurements were performed on a Lambda 950 UV/Vis-NIR spectrophotometer from Perkin Elmer employing quartz cuvettes with a 10 mm path length.
NMR spectra were recorded in DMSO-d6, on a Bruker Avance 300 MHz or 500 MHz and all chemical shifts are given relative to tetramethylsilane (TMS).

3.3. Synthesis of the Ligand

3.3.1. Synthesis of the Ligand Precursor 1,10-phenanthroline-5,6-dione (Phendione)

1,10-Phenanthroline (55.5 mmol) was added in small portions under stirring to sulfuric acid (65%, 80 mL) and left to dissolve at room temperature. Potassium bromate (62 mmol) was added in portions over a period of 3 h and the mixture was stirred at room temperature for 24 h. Then, the mixture was poured over ice and was neutralized to pH 7 using sodium carbonate. The mixture was extracted with chloroform and the organic phase was dried over magnesium sulfate during the night. The solution was then filtered and evaporated to dryness. The crude product was recrystallized from methanol to obtain the desired yellow product.
Yield: 8.4 g (71.8%).
IR (KBr, cm−1): 3062, 1686, 1580, 1562, 1460, 1418, 1290, 1205, 1116, 923, 816, 747.
1H-NMR (500 MHz, DMSO-d6) δ ppm 7.70 (dd, 2H, J = 8.1, 4.8 Hz); 8.40 (dd, 2H, J = 8.1, 1.8 Hz); 8.99 (dd, 2H, J = 4.8, 1.8 Hz).

3.3.2. Synthesis of the Ligand Dipyrido[3,2-a:2′,3′-c]phenazine (dppz)

Phendione (0.24 mmol) was dissolved in ethanol (96%, 4 mL) at 75 °C, o-phenylenediamine (0.24 mmol) was added and the mixture was heated for 30 min under reflux. After cooling to room temperature, the dppz ligand was precipitated. The product was isolated, washed with methanol and dried under vacuum.
Yield: 50 mg (73.5%).
IR (KBr, cm−1): 3026, 1589, 1575, 1485, 1477, 1445, 1405, 1361, 1125, 1208, 1112, 1072, 1053, 1029, 922, 847, 836, 807, 739.
1H-NMR (500 MHz, DMSO-d6) δ ppm 7.97 (dd, 2H, J = 8.1, 4.4 Hz); 8.09 (m, 2H); 8.42 (m, 2H); 9.24 (dd, 2H, J = 4.3, 1.8 Hz); 9.56 (m, 2H).

3.4. Synthesis of the Complexes

The starting lanthanide nitrate salt (0.06 mmol) was dissolved in a mixture of nitromethane/methanol (1/1, 12 mL) and heated at 40 °C. To this, a solution of dppz ligand (0.12 mmol) in warm methanol (8 mL) was added dropwise with stirring, and the reaction mixture was left for 2 h, at 40 °C. During that period, the desired complex precipitated. The product was filtered off, washed with nitromethane (2 mL), water (1 mL) and ether (2 mL) and dried under reduced pressure. The filtrate was set up for crystallization via vapor diffusion of acetonitrile or isopropanol as antisolvents.
(C18H10N4)2Ce(NO3)3·H2O (1).
Yield: 30 mg (55%). Anal. Calcd. for (C18H10N4)2Ce(NO3)3·H2O, %: C 47.58, H 2.44, N 16.95. Found, %: C 47.79, H 2.00, N 16.35. IR (KBr, cm−1): 3100–3580, 3095, 1586, 1578, 1494, 1441, 1420, 1364, 1340, 1303, 1231, 1137, 1128, 1079, 1047, 1034, 844, 813, 795, 776.
(C18H10N4)2Pr(NO3)3·0.25H2O) (2).
Yield: 35 mg (65%). Anal. Calcd. for (C18H10N4)2Pr(NO3)3·0.25H2O, %: C 48.26, H 2.31, N 17.20. Found, %: C 47.94, H 2.04, N 16.65. IR (KBr, cm−1): 3570, 3095, 1599, 1586, 1577, 1498, 1440, 1420, 1364, 1340, 1303, 1231, 1137, 1128, 1079, 1046, 1032, 844, 822, 795, 762.
(C18H10N4)2Nd(NO3)3·0.5H2O (3).
Yield: 31 mg (57%). Anal. Calcd. for (C18H10N4)2Nd(NO3)3·0.5H2O, %: C 47.84, H 2.34, N 17.05. Found, %: C 47.67, H 2.00, N 16.45. IR (KBr, cm−1): 3094, 1597, 1584, 1576, 1493, 1442, 1421, 1365, 1340, 1302, 1236, 1137, 1129, 1079, 1048, 1033, 845, 822, 791, 761.
(C18H10N4)2Sm(NO3)3·0.75H2O (4).
Yield: 30 mg (55%). Anal. Calcd. for (C18H10N4)2Sm(NO3)3·0.75H2O, %: C 47.28, H 2.37, N 16.85. Found, %: C 46.96, H 1.89, N 16.29. IR (KBr, cm−1): 3100-3560, 3095, 1600, 1586, 1578, 1497, 1441, 1420, 1363, 1340, 1302, 1231, 1137, 1128, 1079, 1047, 1034, 843, 822, 795, 776, 762.
(C18H10N4)2Eu(NO3)3·0.5H2O (5).
Yield: 36 mg (66%). Anal. Calcd. for (C18H10N4)2Eu(NO3)3·0.5H2O, %: C 47.43, H 2.32, N 16.90. Found, %: C 47.28, H 1.88, N 16.34. IR (KBr, cm−1): 3400-3560, 3095, 1600, 1586, 1577, 1497, 1490, 1473, 1441, 1420, 1363, 1340, 1309, 1230, 1137, 1127, 1079, 1047, 1035, 844, 822, 795, 775, 762.
(C18H10N4)2Tb(NO3)3·0.25H2O (6).
Yield: 35 mg (64%). Anal. Calcd. for (C18H10N4)2Tb(NO3)3·0.25H2O, %: C 47.30, H 2.26, N 16.86. Found, %: C 46.89, H 1.97, N 16.34. IR (KBr, cm−1): 3400-3560, 3096, 1600, 1589, 1576, 1496, 1490, 1473, 1441, 1419, 1364, 1339, 1308, 1231, 1138, 1126, 1077, 1047, 1036, 844, 822, 795, 776, 762.
(C18H10N4)2Dy(NO3)3·0.25H2O (7).
Yield: 36 mg (65%). Anal. Calcd. for (C18H10N4)2Dy(NO3)3·0.25H2O, %: C 47.12, H 2.25, N 16.79. Found, %: C 46.60, H 1.96, N 16.34. IR (KBr, cm−1): 3450-3560, 3095, 1600, 1586, 1577, 1497, 1441, 1420, 1363, 1340, 1301, 1230, 1188, 1127, 1078, 1046, 1033, 822, 813, 776, 762, 737.
(C18H10N4)2Ho(NO3)3·0.25H2O (8).
Yield: 31 mg (56%). Anal. Calcd. for (C18H10N4)2Ho(NO3)3·0.25H2O, %: C 47.00, H 2.25, N 16.75. Found, %: C 46.41, H 1.96, N 16.20. IR (KBr, cm−1): 3100–3560, 3096, 1600, 1589, 1574, 1494, 1443, 1423, 1361, 1341, 1302, 1234, 1189, 1125, 1074, 1044, 1031, 821, 815, 771, 760, 734.
(C18H10N4)2Er(NO3)3·0.25H2O (9).
Yield: 37 mg (67%). Anal. Calcd. for (C18H10N4)2Er(NO3)3·0.25H2O, %: C 46.88, H 2.24, N 16.70. Found, %: C 46.49, H 1.98, N 16.14. IR (KBr, cm−1): 3400-3560, 3097, 1601, 1586, 1577, 1498, 1489, 1443, 1420, 1363, 1339, 1312, 1231, 1189, 1138, 1080, 1047, 1029, 822, 812, 773, 763, 737.
(C18H10N4)2Tm(NO3)3·0.5H2O (10).
Yield: 34 mg (61%). Anal. Calcd. for (C18H10N4)2Tm(NO3)3·0.5H2O, %: C 46.57, H 2.28, N 16.59. Found, %: C 46.30, H 1.88, N 16.02. IR (KBr, cm−1): 3550, 3096, 1601, 1586, 1578, 1498, 1489, 1441, 1420, 1364, 1340, 1309, 1231, 1188, 1138, 1127, 1079, 1047, 1035, 1026, 822, 813, 777, 762, 738.
(C18H10N4)2Yb(NO3)3·0.5H2O (11).
Yield: 29 mg (52%). Anal. Calcd. for (C18H10N4)2Yb(NO3)3·0.5H2O, %: C 46.36, H 2.27, N 16.52. Found, %: C 46.10, H 1.99, N 15.99. IR (KBr, cm−1): 3350-3560, 3093, 1600, 1584, 1579, 1495, 1488, 1440, 1421, 1364, 1341, 1313, 1230, 1186, 1132, 1126, 1073, 1046, 1036, 1025, 821, 815, 773, 761, 738.
(C18H10N4)2Lu(NO3)3·0.5H2O (12).
Yield: 28 mg (50%). Anal. Calcd. for (C18H10N4)2Lu(NO3)3·0.5H2O, %: C 46.26, H 2.26, N 16.49. Found, %: C 46.09, H 1.96, N 15.97. IR (KBr, cm−1): 3350-3550, 3095, 1600, 1582, 1578, 1492, 1487, 1441, 1425, 1362, 1342, 1314, 1231, 1184, 1131, 1123, 1071, 1046, 1036, 1024, 821, 813, 777, 767, 732.
1H-NMR (300 MHz, DMSO-d6) δ ppm 7.95 (dd, 2H, J = 8.3, 4.5 Hz); 8.06 (m, 2H); 8.38 (m, 2H); 9.22 (dd, 2H, J = 4.5, 1.9 Hz); 9.54 (dd, 2H, J = 8.3, 1.9 Hz).
13C-NMR (75 MHz, DMSO-d6) δ 124.6; 127.0; 129.2; 131.3; 133.1; 140.8; 141.8; 147.8; 152.4.

3.5. Solubility and Stability of Complexes

The [Ln(NO3)3(dppz)2] complexes were soluble in DMF and DMSO. The solution stability of the [Ln(NO3)3(dppz)2] (Ln = Nd3+, Er3+,Yb3+) in DMF was tested. The solubility in DMF/buffer mixtures (5 mM Tris-HCl, 5 mM NaCl, pH 7.2) was additionally tested.

3.6. Single Crystal X-ray Diffraction Analysis

For all reported structures, X-ray intensity data were collected, at 100 K, on a Rigaku Oxford Diffraction Supernova Dual Source (Cu at zero) diffractometer equipped with an Atlas charge-coupled device (CCD) detector using ω scans and CuKα (λ = 1.54184 Å) radiation. The images were interpreted and integrated with the program CrysAlisPro (Rigaku Oxford Diffraction) [34]. Using Olex2 [35], the structures were solved by direct methods using the ShelXS structure solution program and refined by full-matrix least-squares on F2 using the ShelXL program package [36,37]. Nonhydrogen atoms were anisotropically refined and the hydrogen atoms in the riding mode and isotropic temperature factors fixed at 1.2 times U(eq) of the parent atoms. For all reported structures, a correction for diffuse effects, due to the inclusion of disordered water molecules, was made using the SQUEEZE routine in PLATON [38].
Crystal data for compound: C36H20LaN11O9, M = 889.54, monoclinic, space group P21/c (No. 14), a = 9.5038(4) Å, b = 14.3572(6) Å, c = 25.1669(12) Å, β = 91.800(4)°, V = 3432.3(3) Å3, Z = 4, T = 100 K, ρcalc = 1.721 g cm−3, μ(Cu-Kα) = 10.278 mm−1, F(000) = 1768, 29511 reflections measured, 6908 unique (Rint = 0.0951) which were used in all calculations. The final R1 was 0.0666 (I>2σ(I)) and wR2 was 0.2016 (all data).
Crystal data for compound (1): C36H20CeN11O9, M = 890.75, monoclinic, space group P21/c (No. 14), a = 9.4873(3) Å, b = 14.4189(5) Å, c = 25.1531(6) Å, β = 91.896(2)°, V = 3438.97(18) Å3, Z = 4, T = 100 K, ρcalc = 1.720 g cm−3, μ(Cu-Kα) = 10.886 mm−1, F(000) = 1772, 20269 reflections measured, 6902 unique (Rint = 0.0674) which were used in all calculations. The final R1 was 0.0518 (I>2σ(I)) and wR2 was 0.1398 (all data).
Crystal data for compound (2): C36H20N11O9Pr, M = 891.54, monoclinic, space group P21/c (No. 14), a = 9.46171(12) Å, b = 14.4654(2) Å, c = 25.0861(3) Å, β = 91.9166(12)°, V = 3431.55(8) Å3, Z = 4, T = 100 K, ρcalc = 1.726 g cm−3, μ(Cu-Kα) = 11.550 mm−1, F(000) = 1776, 26255 reflections measured, 6881 unique (Rint = 0.0497) which were used in all calculations. The final R1 was 0.0352 (I>2σ(I)) and wR2 was 0.0924 (all data).
Crystal data for compound (3): C36H20N11NdO9, M = 894.87, monoclinic, space group P21/c (No. 14), a = 9.4493(2) Å, b = 14.5407(4) Å, c = 24.9067(7) Å, β = 92.053(3)°, V = 3419.97(15) Å3, Z = 4, T = 100 K, ρcalc = 1.738 g cm−3, μ(Cu-Kα) = 12.244 mm−1, F(000) = 1780, 23245 reflections measured, 6884 unique (Rint = 0.0409) which were used in all calculations. The final R1 was 0.0374 (I>2σ(I)) and wR2 was 0.1018 (all data).
Crystal data for compound (5): C36H20EuN11O9, M = 902.60, monoclinic, space group P21/c (No. 14), a = 9.3990(2) Å, b = 14.6262(4) Å, c = 24.8352(6) Å, β = 91.972(2)°, V = 3412.11(14) Å3, Z = 4, T = 100 K, ρcalc = 1.757 g cm−3, μ(Cu-Kα) = 13.820 mm−1, F(000) = 1792, 21978 reflections measured, 6860 unique (Rint = 0.0667) which were used in all calculations. The final R1 was 0.0480 (I>2σ(I)) and wR2 was 0.1326 (all data).
Crystal data for compound (9): C36H20ErN11O9, M = 917.89, monoclinic, space group P21/c (No. 14), a = 9.3230(2) Å, b = 14.7818(7) Å, c = 24.6058(10) Å, β = 91.848(3)°, V = 3389.2(2) Å3, Z = 4, T = 100 K, ρcalc = 1.799 g cm−3, μ(Cu-Kα) = 5.262 mm−1, F(000) = 1812, 19595 reflections measured, 6746 unique (Rint = 0.0773) which were used in all calculations. The final R1 was 0.0597 (I>2σ(I)) and wR2 was 0.1667 (all data).
Crystal data for compound (11): C36H20N11O9Yb, M = 923.67, monoclinic, space group P21/c (No. 14), a = 9.3018(3) Å, b = 14.8195(5) Å, c = 24.5502(6) Å, β = 91.654(2)°, V = 3382.79(18) Å3, Z = 4, T = 100 K, ρcalc = 1.814 g cm−3, μ(Cu-Kα) = 5.781 mm−1, F(000) = 1820, 20841 reflections measured, 6619 unique (Rint = 0.0766) which were used in all calculations. The final R1 was 0.0498 (I>2σ(I)) and wR2 was 0.1331 (all data).
Crystal data for compound (12): C36H20LuN11O9, M = 925.60, monoclinic, space group P21/c (No. 14), a = 9.2924(2) Å, b = 14.8631(5) Å, c = 24.4840(7) Å, β = 91.488(2)°, V = 3380.44(17) Å3, Z = 4, T = 100 K, ρcalc = 1.819 g cm−3, μ(Cu-Kα) = 6.258 mm−1, F(000) = 1824, 25239 reflections measured, 6807 unique (Rint = 0.0590) which were used in all calculations. The final R1 was 0.0375 (I>2σ(I)) and wR2 was 0.1012 (all data).
CCDC2034576-2034583 contain the supplementary crystallographic data for this paper and can be obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html (or from the Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax: +44-1223-336033; or [email protected]).

3.7. CT-DNA Binding Study

CT-DNA was dissolved in Tris-HCl/NaCl buffer (5 mM, pH = 7.2). The DNA was left for several hours to completely dissolve, no sonication was used. The ratio of the absorbance values of the CT-DNA at 260 and 280 nm was ∼1.9, confirming the CT-DNA is free from protein impurities. The CT-DNA concentration was determined by absorption spectroscopy using a molar absorption coefficient value of 6600 M−1 cm−1 at 260 nm for CT-DNA [29]. The initial concentration of the CT-DNA was determined to 14.15 mM. The EthB was also dissolved in the Tris-HCl/NaCl buffer (5 mM, pH = 7.2) to obtain an initial concentration of 2.54 mM. Subsequently, 250 μL of both the CT-DNA and EthB solutions were added in a quartz cuvette (Starna cuvette type 23/Q/10) with a path length of 10 mm yielding a [CT-DNA] = 7.26 mM and [EthB] = 1.27 mM. The tested [Nd(NO3)3(dppz)2] complex was dissolved in DMF (14 mM) and the appropriate amount was used for the DNA binding study. The competitive binding assay from EthB displacement was carried out by measuring the emission intensities of EthB bound to CT-DNA solution with the gradual increase of the complex concentrations (27.9–406.9 μM; taking into account the dilution). The EthB was excited at 546 nm and observed at 603 nm (emission maximum). EthB showed very weak emission in the Tris-buffer due to fluorescent quenching of the free EthB in buffer. CT-DNA-bound EthB showed significant enhancement in emission intensity.

4. Conclusions

Herein, we report the synthetic procedures and the spectroscopic and single crystal X-ray diffraction characteristics for a series of lanthanide complexes containing dipyrido[3,2-a:2′,3′-c]phenazine (dppz) as ligand. Our synthetic approach is novel and is able to afford single crystals suitable for X-ray diffraction analysis for most of the compounds in the lanthanide series. X-ray analysis of the complexes reveals that all complexes are isomorphic, with the lanthanide ion coordinated by two dppz ligands and three nitrate anions. As it could be expected based on the T1 state of the ligand (18400 cm−1) and the resonant energy level of the studied lanthanides (Nd3+, Er3+, Yb3+), it was shown that the dppz ligand is an appropriate choice for the design of NIR emitting complexes. We have additionally studied the stability of the [Nd(NO3)3(dppz)2], [Er(NO3)3(dppz)2] and [Yb(NO3)3(dppz)2] complexes in solution over a period of time. No visible changes in the UV/Vis spectra were observed up to 6 h. Last, we have confirmed that the exemplary [Nd(NO3)3(dppz)2] complex shows DNA intercalation ability through an ethidium bromide displacement assay carried out with CT-DNA. These results point out that such carefully developed lanthanide polypyridyl complexes could serve as potential NIR luminescent probes for bioimaging applications and diagnostics.

Supplementary Materials

The following are available online, Scheme S1: Synthesis of 1,10-phenanthroline-5,6-dione. Scheme S2: Synthesis of dipyrido[3,2-a:2′,3′-c]phenazine. Figure S1: Steady-state excitation spectrum of Eu(dppz)2(NO3)3, recorded at room temperature. Figure S2: Steady-state emission spectrum of Eu(dppz)2(NO3)3 at room temperature. Figure S3: UV-Vis absorption spectra of the [Er(dppz)2 (NO3)3] complex carried out over a range of 6 h in DMF. Figure S4: UV-Vis absorption spectra of the [Yb(dppz)2 (NO3)3] complex carried out over a range of 6 h in DMF. Figure S5: UV/Vis absorption spectrum of [Yb(NO3)3(dppz)2] complex dissolved in DMF: Tris buffer (5 mM Tris-HCl, 5 mM NaCl, pH = 7.2) in a 1: 1 ratio. The UV-Vis spectrum was recorded 2 h after dissolving the sample. Figure S6: UV-Vis absorption spectrum of [Yb(dppz)2(NO3)3] complex dissolved in Tris buffer (5 mM Tris-HCl, 5 mM NaCl, pH = 7.2). The UV/Vis spectrum was recorded 2 h after dissolving the sample.

Author Contributions

Conceptualization, R.V.D. and K.V.H.; methodology, A.S., A.M.K., K.V.H.; validation, A.S., A.M.K., R.V.D and K.V.H.; formal analysis, A.S., A.M.K. and K.V.H.; investigation, A.S. and A.M.K.; resources, R.V.D. and K.V.H.; writing—original draft preparation, A.S. and A.M.K.; writing—review and editing, R.V.D. and K.V.H.; visualization, A.S., A.M.K. and K.V.H.; supervision, R.V.D. and K.V.H.; project administration, R.V.D.; funding acquisition, R.V.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Erasmus Mundus Basileus V project, the Fonds Wetenschappelijk Onderzoek, grant numbers AUGE/11/029, AUGE/09/024 and 01N03217 and the Bijzonder Onderzoeksfonds UGent, grant number BOF15/PDO/091.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

References

  1. Eliseeva, S.V.; Bünzli, J.-C.G. Lanthanide luminescence for functional materials and bio-sciences. Chem. Soc. Rev. 2010, 39, 189–227. [Google Scholar] [PubMed]
  2. Binnemans, K. Lanthanide-based luminescent hybrid materials. Chem. Rev. 2009, 109, 4283–4374. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Werts, M.H.V. Making sense of lanthanide luminescence. Sci. Prog. 2005, 88, 101–131. [Google Scholar] [CrossRef] [PubMed]
  4. Bünzli, J.-C.G. On the design of highly luminescent lanthanide complexes. Coord. Chem. Rev. 2015, 293, 19–47. [Google Scholar] [CrossRef]
  5. Bünzli, J.-C.G.; Eliseeva, S.V. Intriguing aspects of lanthanide luminescence. Chem. Sci. 2013, 4, 1939–1949. [Google Scholar] [CrossRef]
  6. Debroye, E.; Parac-Vogt, T.N. Towards polymetallic lanthanide complexes as dual contrast agents for magnetic resonance and optical imaging. Chem. Soc. Rev. 2014, 43, 8178–8192. [Google Scholar] [CrossRef] [Green Version]
  7. Morrow, J.R.; Buttrey, L.A.; Shelton, V.M.; Berback, K.A. Efficient catalytic cleavage of RNA by lanthanide(III) macrocyclic complexes—Toward synthetic nucleases for invivo applications. J. Am. Chem. Soc. 1992, 114, 1903–1905. [Google Scholar] [CrossRef]
  8. Franklin, S.J. Lanthanide-mediated DNA hydrolysis. Curr. Opin. Chem. Biol. 2001, 5, 201–208. [Google Scholar] [CrossRef]
  9. Larson, S.M.; Carrasquillo, J.A.; Cheung, N.K.V.; Press, O.W. Radioimmunotherapy of human tumours. Nat. Rev. Cancer 2015, 15, 347–360. [Google Scholar] [CrossRef]
  10. Park, J.Y.; Chang, Y.; Lee, G.H. Multi-modal imaging and cancer therapy using lanthanide oxide nanoparticles: Current status and perspectives. Curr. Med. Chem. Biol. 2015, 22, 569–582. [Google Scholar] [CrossRef]
  11. Bünzli, J.-C.G.; Eliseeva, S.V. Lanthanide NIR luminescence for telecommunications, bioanalyses and solar energy conversion. J. Rare Earths 2010, 6, 824–842. [Google Scholar] [CrossRef]
  12. Bünzli, J.-C.G.; Piguet, C. Taking advantage of luminescent lanthanide ions. Chem. Soc. Rev. 2005, 34, 1048–1077. [Google Scholar] [CrossRef] [PubMed]
  13. Singh, K.; Banerjee, S.; Patra, A.K. Photocytotoxic luminescent lanthanide complexes of DTPA-bisamide using quinoline as photosensitizer. RSC Adv. 2015, 5, 107503–107513. [Google Scholar] [CrossRef]
  14. Chandra, A.; Singh, K.; Singh, S.; Sivakumar, S.; Patra, A.K. A luminescent europium(III)-platinum(II) heterometallic complex as a theranostic agent: A proof-of-concept study. Dalton Trans. 2016, 45, 494–497. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Hussain, A.; Somyajit, K.; Banik, B.; Banerjee, S.; Nagaraju, G.; Chakravarty, A.R. Enhancing the photocytotoxic potential of curcumin on terpyridyl lanthanide(III) complex formation. Dalton Trans. 2013, 42, 182–195. [Google Scholar] [CrossRef]
  16. Campello, M.P.C.; Palma, E.; Correia, I.; Paulo, P.M.R.; Matos, A.; Rino, J.; Coimbra, J.; Pessoa, J.C.; Gambino, D.; Paulo, A.; et al. Lanthanide complexes with phenanthroline-based ligands: Insights into cell death mechanisms obtained by microscopy techniques. Dalton Trans. 2019, 48, 4611–4624. [Google Scholar] [CrossRef]
  17. Bünzli, J.-C.G. Lanthanide luminescence for biomedical analyses and imaging. Chem. Rev. 2010, 110, 2729–2755. [Google Scholar] [CrossRef]
  18. Sun, Q.; Yan, P.; Niu, W.; Chu, W.; Yao, X.; An, G.; Li, G. NIR luminescence of a series of benzoyltrifluoroacetone erbium complexes. RSC Adv. 2015, 5, 65856–65861. [Google Scholar] [CrossRef]
  19. Fan, S.; Yao, X.; Li, J.; Li, W.; Li, G. Near-infrared luminescent materials: From β-diketonate ytterbium complexes to β-diketonate-ytterbium-complex@PMMA thin film. J. Lumin. 2018, 203, 473–480. [Google Scholar] [CrossRef]
  20. Dasari, S.; Singh, S.; Kumar, P.; Sivakumar, S.; Patra, A.K. Near-infrared excited cooperative upconversion in luminescent ytterbium(III) bioprobes as light-responsive theranostic agents. Eur. J. Med. Chem. 2019, 163, 546–559. [Google Scholar] [CrossRef]
  21. McQuaid, K.T.; Cardin, C.J. Chapter Twelve—The eyes have it: Using X-ray crystallography to determine the binding modes of medically relevant ruthenium/DNA complexes. Adv. Inorg. Chem. 2020, 75, 393–424. [Google Scholar]
  22. Hussain, A.; Lahiri, D.; Begum, M.S.A.; Saha, S.; Majumdar, R.; Dighe, R.R.; Chakravarty, A.R. Photocytotoxic lanthanum(III) and gadolinium(III) complexes of phenanthroline bases showing light-induced DNA cleavage activity. Inorg. Chem. 2010, 49, 4036–4045. [Google Scholar] [CrossRef] [PubMed]
  23. Zheng, R.H.; Guo, H.C.; Jiang, H.J.; Xu, K.H.; Liu, B.B.; Sun, W.L.; Shen, Z.Q. A new and convenient synthesis of phendiones oxidated by KBrO3/H2SO4 at room temperature. Chin. Chem. Lett. 2010, 21, 1270–1272. [Google Scholar] [CrossRef]
  24. Dupureur, C.M.; Barton, J.K. Structural studies of lambda- and delta-[Ru(phen)(2)dppz](2+) bound to d(GTCGAC)(2): Characterization of enantioselective intercalation. Inorg. Chem. 1997, 36, 33–43. [Google Scholar] [CrossRef] [Green Version]
  25. Dasari, S.; Patra, A.K. Luminescent europium and terbium complexes of dipyridoquinoxaline and dipyridophenazine ligands as photosensitizing antennae: Structures and biological perspectives. Dalton Trans. 2015, 44, 19844–19855. [Google Scholar] [CrossRef]
  26. Chen, W.T.; Fukuzumi, S. Ligand-dependent ultrasonic-assistant self-assemblies and photophysical properties of lanthanide nicotinic/isonicotinic complexes. Inorg. Chem. 2009, 48, 3800–3807. [Google Scholar] [CrossRef]
  27. Monguzzi, A.; Tubino, R.; Meinardi, F.; Biroli, A.O.; Pizzotti, M.; Demartin, F.; Quochi, F.; Cordella, F.; Loi, M.A. Novel Er3+ perfluorinated complexes for broadband sensitized near infrared emission. Chem. Mater. 2009, 21, 128–135. [Google Scholar] [CrossRef] [Green Version]
  28. Glover, P.B.; Bassett, A.P.; Nockemann, P.; Kariuki, B.M.; Van Deun, R.; Pikramenou, Z. Fully fluorinated imidodiphosphinate shells for visible- and NIR-emitting lanthanides: Hitherto unexpected effects of sensitizer fluorination on lanthanide emission properties. Chem. Eur. J. 2007, 13, 6308–6320. [Google Scholar] [CrossRef]
  29. Dasari, S.; Abbas, Z.; Kumar, P.; Patra, A.K. Photosensitized samarium(III) and erbium(III) complexes of planar N,N-donor heterocyclic bases: Crystal structures and evaluation of biological activity. CrystEngComm 2016, 18, 4313–4322. [Google Scholar] [CrossRef]
  30. Horrocks, W.D., Jr.; Sudnick, D.R. Lanthanide ion probes of structure in biology—Laser-induced luminescence decay constants provide a direct measure of the number of metal-coordinated water molecules. J. Am. Chem. Soc. 1979, 101, 334–340. [Google Scholar] [CrossRef]
  31. Beeby, A.; Clarkson, I.M.; Dickins, R.S.; Faulkner, S.; Parker, D.; Royle, L.; de Sousa, A.S.; Williams, J.A.G.; Woods, M.J. Non-radiative deactivation of the excited states of europium, terbium and ytterbium complexes by proximate energy-matched OH, NH and CH oscillators: An improved luminescence method for establishing solution hydration states. J. Chem. Soc. Perkin Trans. 1999, 2, 493–504. [Google Scholar] [CrossRef]
  32. Chen, G.-J.; Qiao, X.; Tian, J.-L.; Xu, J.-Y.; Gu, W.; Liu, X.; Yan, S.-P. Synthesis, DNA binding, photo-induced DNA cleavage and cytotoxicity studies of europium(III) complexes. Dalton Trans. 2010, 39, 10637–10643. [Google Scholar] [CrossRef]
  33. Maity, B.; Gadadhar, S.; Goswami, T.K.; Karande, A.A.; Chakravarty, A.R. Photo-induced anticancer activity of polypyridyl platinum(II) complexes. Eur. J. Med. Chem. 2012, 57, 250–258. [Google Scholar] [CrossRef] [PubMed]
  34. Rigaku Oxford Diffraction. CrysAlisPro Software System, version 1.171.38.41; Rigaku Corporation: Oxford, UK, 2018. [Google Scholar]
  35. Dolomanov, O.V.; Bourhis, L.J.; Gildea, R.J.; Howard, J.A.K.; Puschmann, H. OLEX2: A complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341. [Google Scholar] [CrossRef]
  36. Sheldrick, G.M. A short history of SHELX. Acta Crystallogr. Sect. A 2008, 64, 112–122. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Sheldrick, G.M. SHELXT—Integrated space-group and crystal-structure determination. Acta Crystallogr. Sect. C 2015, 71, 3–8. [Google Scholar] [CrossRef] [PubMed]
  38. Spek, A.L. Single-crystal structure validation with the program PLATON. J. Appl. Cryst. 2003, 36, 7–13. [Google Scholar] [CrossRef] [Green Version]
Sample Availability: Samples of the compounds 112 are available from the authors
Scheme 1. Synthesis of the [Ln(NO3)3(dppz)2] complexes (Ln = Ce3+, Pr3+, Nd3+, Sm3+, Eu3+, Tb3+, Dy3+, Ho3+, Er3+, Tm3+, Yb3+, Lu3+).
Scheme 1. Synthesis of the [Ln(NO3)3(dppz)2] complexes (Ln = Ce3+, Pr3+, Nd3+, Sm3+, Eu3+, Tb3+, Dy3+, Ho3+, Er3+, Tm3+, Yb3+, Lu3+).
Molecules 25 05309 sch001
Figure 1. Asymmetric unit of the crystal structure of [Nd(NO3)3(dppz)2], showing thermal displacement ellipsoids at the 50% probability level, atom labeling scheme of the hetero atoms and polyhedron representation of the coordination environment of the Nd3+ ion.
Figure 1. Asymmetric unit of the crystal structure of [Nd(NO3)3(dppz)2], showing thermal displacement ellipsoids at the 50% probability level, atom labeling scheme of the hetero atoms and polyhedron representation of the coordination environment of the Nd3+ ion.
Molecules 25 05309 g001
Scheme 2. Schematic simplified energy level diagram of the dppz ligand and selected lanthanides employed in the study. Favorable energy transfer processes from the dppz to Ln3+ ions are shown as orange dotted arrows.
Scheme 2. Schematic simplified energy level diagram of the dppz ligand and selected lanthanides employed in the study. Favorable energy transfer processes from the dppz to Ln3+ ions are shown as orange dotted arrows.
Molecules 25 05309 sch002
Figure 2. Excitation (left) and emission (right) steady-state spectra of the [Nd(NO3)3(dppz)2] complex measured at room temperature. The labeled peaks a–d and a–c, in the excitation and emission spectrum, respectively, have been assigned to appropriate transitions in Table 1.
Figure 2. Excitation (left) and emission (right) steady-state spectra of the [Nd(NO3)3(dppz)2] complex measured at room temperature. The labeled peaks a–d and a–c, in the excitation and emission spectrum, respectively, have been assigned to appropriate transitions in Table 1.
Molecules 25 05309 g002
Figure 3. Excitation (left) and emission (right) steady-state spectra of the [Er(NO3)3(dppz)2] complex measured at room temperature. The broad emission band is referred to as peak “a” in Table 1.
Figure 3. Excitation (left) and emission (right) steady-state spectra of the [Er(NO3)3(dppz)2] complex measured at room temperature. The broad emission band is referred to as peak “a” in Table 1.
Molecules 25 05309 g003
Figure 4. Excitation (left) and emission (right) steady-state spectra of the [Yb(NO3)3(dppz)2] complex measured at room temperature. The broad emission band is referred to as peak “a” in Table 1.
Figure 4. Excitation (left) and emission (right) steady-state spectra of the [Yb(NO3)3(dppz)2] complex measured at room temperature. The broad emission band is referred to as peak “a” in Table 1.
Molecules 25 05309 g004
Figure 5. Decay profile of the [Nd(NO3)3(dppz)2] complex.
Figure 5. Decay profile of the [Nd(NO3)3(dppz)2] complex.
Molecules 25 05309 g005
Figure 6. Decay profile of the Er(dppz)2(NO3)3 complex.
Figure 6. Decay profile of the Er(dppz)2(NO3)3 complex.
Molecules 25 05309 g006
Figure 7. Decay profile of the [Yb(NO3)3(dppz)2] complex.
Figure 7. Decay profile of the [Yb(NO3)3(dppz)2] complex.
Molecules 25 05309 g007
Figure 8. UV-Vis absorption spectra of the [Nd(NO3)3(dppz)2] complex carried out over a range of 6 h in DMF.
Figure 8. UV-Vis absorption spectra of the [Nd(NO3)3(dppz)2] complex carried out over a range of 6 h in DMF.
Molecules 25 05309 g008
Figure 9. Emission spectral traces of EthB bound CT-DNA with increasing [Nd(NO3)3(dppz)2] additions (1–15 µL range; 14 mM). The measurements were carried out in 5 mM Tris-HCl/NaCl buffer (pH = 7.2) at RT; λex = 546 nm, λem, max. = 603 nm.
Figure 9. Emission spectral traces of EthB bound CT-DNA with increasing [Nd(NO3)3(dppz)2] additions (1–15 µL range; 14 mM). The measurements were carried out in 5 mM Tris-HCl/NaCl buffer (pH = 7.2) at RT; λex = 546 nm, λem, max. = 603 nm.
Molecules 25 05309 g009
Table 1. Assignment of the labeled transitions a-d in the steady-state excitation and emission spectra of the Nd3+, Er3+ and Yb3+ complexes.
Table 1. Assignment of the labeled transitions a-d in the steady-state excitation and emission spectra of the Nd3+, Er3+ and Yb3+ complexes.
ExcitationEmission
Wavelength (nm)Energy (cm−1)Transition Wavelength (nm)Energy (cm−1)Transition
NdL
a465.5214822D3/2, 2P3/2, 2G9/2, 2K15/24I9/2a870.8114844F3/24I9/2
b512.2195244G9/2, 4G7/22K13/24I11/2b1052.79499 4I11/2
c524.3190734G9/2, 4G7/2, 2K13/24I9/2c1334.57493 4I13/2
d582.4171702G7/2, 4G5/24I9/2
ErL
no f-f transitionsa1529.065484I13/24I15/2
YbL
no f-f transitionsa977.6102292F5/22F7/2
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Savić, A.; Kaczmarek, A.M.; Van Deun, R.; Van Hecke, K. DNA Intercalating Near-Infrared Luminescent Lanthanide Complexes Containing Dipyrido[3,2-a:2′,3′-c]phenazine (dppz) Ligands: Synthesis, Crystal Structures, Stability, Luminescence Properties and CT-DNA Interaction. Molecules 2020, 25, 5309. https://doi.org/10.3390/molecules25225309

AMA Style

Savić A, Kaczmarek AM, Van Deun R, Van Hecke K. DNA Intercalating Near-Infrared Luminescent Lanthanide Complexes Containing Dipyrido[3,2-a:2′,3′-c]phenazine (dppz) Ligands: Synthesis, Crystal Structures, Stability, Luminescence Properties and CT-DNA Interaction. Molecules. 2020; 25(22):5309. https://doi.org/10.3390/molecules25225309

Chicago/Turabian Style

Savić, Aleksandar, Anna M. Kaczmarek, Rik Van Deun, and Kristof Van Hecke. 2020. "DNA Intercalating Near-Infrared Luminescent Lanthanide Complexes Containing Dipyrido[3,2-a:2′,3′-c]phenazine (dppz) Ligands: Synthesis, Crystal Structures, Stability, Luminescence Properties and CT-DNA Interaction" Molecules 25, no. 22: 5309. https://doi.org/10.3390/molecules25225309

APA Style

Savić, A., Kaczmarek, A. M., Van Deun, R., & Van Hecke, K. (2020). DNA Intercalating Near-Infrared Luminescent Lanthanide Complexes Containing Dipyrido[3,2-a:2′,3′-c]phenazine (dppz) Ligands: Synthesis, Crystal Structures, Stability, Luminescence Properties and CT-DNA Interaction. Molecules, 25(22), 5309. https://doi.org/10.3390/molecules25225309

Article Metrics

Back to TopTop